Literature DB >> 4530305

Purification of naked intranuclear particles from human liver infected by hepatitis B virus.

S Z Hirschman, M Gerber, E Garfinkel.   

Abstract

The isolation and purification of the naked intranuclear particles of a human liver infected with hepatitis B virus is described. The particles had a diameter of 27-28 nm, were hexagonal, and showed the presence of capsomeres and spikes with lengths of 7-10 nm projecting from the surfaces. The particles formed cubic arrays with center-to-center distances of 40-42 nm. The overall particle symmetry was icosahedral. The ultraviolet absorption spectrum of the particles showed a peak at 264 nm with a shoulder at 280 nm. Endogenous DNA polymerase activity was not detected in fractions containing particles. DNA polymerase activity was present when activated DNA or d(A-T)(n) was used as exogenous template.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4530305      PMCID: PMC433768          DOI: 10.1073/pnas.71.9.3345

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Inhibitors of viral nucleic acid transcriptases.

Authors:  S Z Hirschman
Journal:  Trans N Y Acad Sci       Date:  1971-06

2.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

3.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

4.  Periarteritis nodosa, Australia antigen and lymphatic leukemia.

Authors:  M A Gerber; A Brodin; D Steinberg; S Vernace; C P Yang; F Paronetto
Journal:  N Engl J Med       Date:  1972-01-06       Impact factor: 91.245

5.  The heterogeneity of Australia antigen.

Authors:  G L Le Bouvier
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

6.  D.N.A. polymerase in preparations containing Australia antigen.

Authors:  S Z Hirschman; S J Vernace; F Schaffner
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

7.  Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders.

Authors:  A Nowoslawski; W J Brzosko; K Madaliński; K Krawczyński
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

8.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

9.  DNA-dependent DNA polymerases from HeLa cell nuclei. II. Template and substrate utilization.

Authors:  A Schlabach; B Fridlender; A Bolden; A Weissbach
Journal:  Biochem Biophys Res Commun       Date:  1971-08-20       Impact factor: 3.575

10.  Electron microscopic observations and speculations on Australia antigen.

Authors:  J D Almeida
Journal:  Postgrad Med J       Date:  1971-07       Impact factor: 2.401

View more
  11 in total

1.  Demonstration of subpopulations of Dane particles.

Authors:  P M Kaplan; E C Ford; R H Purcell; J L Gerin
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  HBs-Ag, HBc-Ag and virus-like particles in liver tissue.

Authors:  S Furuta; A Nagata; K Kiyosawa; T Takahashi; Y Akahane
Journal:  Gastroenterol Jpn       Date:  1975

3.  Distinct deoxyribonucleic acid polymerase activities associated with Dane particles and naked Dane cores.

Authors:  D W Bradley; R M Fields; J E Maynard
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA.

Authors:  J K Christman; M Gerber; P M Price; C Flordellis; J Edelman; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Characterization and demonstration of human liver-specific protein (LSP) and apo-LSP.

Authors:  N Lebwohl; M A Gerber
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen-associated delta antigen.

Authors:  O Crivelli; M Rizzetto; C Lavarini; A Smedile; J L Gerin
Journal:  J Clin Microbiol       Date:  1981-08       Impact factor: 5.948

Review 7.  The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

Authors:  S Z Hirschman
Journal:  Mol Cell Biochem       Date:  1979-07-15       Impact factor: 3.396

8.  Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA.

Authors:  T Tsurimoto; A Fujiyama; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Expression of cloned hepatitis B virus DNA in human cell cultures.

Authors:  S Z Hirschman; P Price; E Garfinkel; J Christman; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Effect of alkaline glutaraldehyde on hepatitis B virus antigens.

Authors:  K Adler-Storthz; L M Sehulster; G R Dreesman; F B Hollinger; J L Melnick
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.